OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the incretin system in obesity and type 2 diabetes mellitus
Saleem Ansari, Bernard Khoo, Tricia Tan
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 8, pp. 447-459
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Emerging Pharmacotherapies for Obesity: A Systematic Review
Michail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 9

Gut hormones and bone homeostasis: potential therapeutic implications
Béatrice Bouvard, Guillaume Mabilleau
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 7

Metabolic alliance: pharmacotherapy and exercise management of obesity
Javier Butragueño, Jonatan R. Ruiz
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 505-506
Closed Access | Times Cited: 6

Skeletal muscle loss and sarcopenia in obesity pharmacotherapy
David C. D. Hope, Tricia Tan
Nature Reviews Endocrinology (2024)
Closed Access | Times Cited: 5

Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Giovanni Targher, Alessandro Mantovani, Christopher D. Byrne, et al.
Gut (2024), pp. gutjnl-334023
Closed Access | Times Cited: 4

SGLT2 inhibitors and dietary calorie restriction for type 2 diabetes remission
David C. D. Hope, Jonathan Valabhji
BMJ (2025), pp. r40-r40
Closed Access

EValuating Glucose ContrOL Using a Next-GeneraTION Automated Insulin Delivery Algorithm in Patients with Type 1 and Type 2 Diabetes: The EVOLUTION Study
Tom Wilkinson, Renee A. Meier, Niranjala Hewapathirana, et al.
Diabetes Technology & Therapeutics (2025)
Closed Access

Triazination/IEDDA Cascade Modular Strategy Installing Pyridines/Pyrimidines onto Tyrosine Enables Peptide Screening and Optimization
Quan Zuo, Xinyi Song, Jie Yan, et al.
Journal of the American Chemical Society (2025)
Closed Access

Exogenous oral application of PYY and exendin-4 impacts upon taste-related behavior and taste perception in wild-type mice
Sivaraman Iyer, Jean‐Pierre Montmayeur, Sergei Zolotukhin, et al.
Neuropharmacology (2025), pp. 110408-110408
Closed Access

How to Enhance Cardiorenal Benefits in Patients With Chronic Heart Failure?
Toshihide Izumida, Koichiro Kinugawa
International Journal of Heart Failure (2025) Vol. 7
Open Access

Expanding applications of GLP-1 therapies: a careful view
Domenico Azzolino, Tiziano Lucchi
International Journal of Obesity (2025)
Closed Access

Nanotechnology applications in the regulation of metabolic diseases
Yan Li, Yongfei Fan, Haibo Yang, et al.
Coordination Chemistry Reviews (2025) Vol. 538, pp. 216736-216736
Closed Access

Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy
Anindya Samanta, Darius D. Bordbar, Christina Y. Weng, et al.
International Ophthalmology Clinics (2024) Vol. 65, Iss. 1, pp. 23-26
Closed Access | Times Cited: 2

An open‐label 16‐week study of liraglutide in adolescents with obesity post‐sleeve gastrectomy
Anna Zenno, Ejike E. Nwosu, Syeda Fatima, et al.
Pediatric Obesity (2024) Vol. 19, Iss. 11
Closed Access | Times Cited: 1

Intestinal stearoyl-coenzyme A desaturase-inhibition improves obesity-associated metabolic disorders
Yangliu Xia, Yang Zhang, Zhipeng Zhang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 892-908
Open Access | Times Cited: 1

An oral hypoglycemic agent for T2DM with the function of alleviating multi-complications
Shiyong Zhang, Xiao Xiao, Xiaoluan Lu, et al.
Research Square (Research Square) (2024)
Open Access

In vivo Antibody Painting for Next Generation Weight Loss Drugs
Katsushi Kitahara, Aurélie Rondon, Edward Miller, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Influência da cirurgia bariátrica no tratamento de Diabetes Mellitus tipo 2
Camila Guidi Rossi, Daniela Annunziata Masaro, Felipe Vieira Ramos, et al.
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 4, pp. e72190-e72190
Open Access

Design, Synthesis, molecular dynamic analysis, and In-Vivo anti-diabetic evaluation of novel hydrazine carboximidamide derivatives
Hannane Fathi, Nima Naderi, Seyedali Hashemi, et al.
Results in Chemistry (2024) Vol. 11, pp. 101791-101791
Open Access

The GLP-1 analogue, exendin-4, improves bone material properties and strength through a central relay in ovariectomized mice
Morgane Mermet, Jessica Denom, A. Mieczkowska, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top